Article: Clinical Experience, Pathophysiology, and Considerations in the Prophylaxis and Treatment of Hypercoagulopathy of COVID-19: A Review Study.
Iranian journal of medical sciences
2019 Volume 46, Issue 1, Page(s) 1–14
Abstract: ... a summary of the considerations for the prophylaxis and treatment of such complications in the adult ... Several expert panels have published recommendations regarding the prophylaxis and treatment ... complications of coronavirus disease 2019 (COVID-19). It is suggested that the hyperinflammatory response and ...
| Abstract | Since the emergence of the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) pandemic, an increasing number of reports and studies have tried to warn the medical community about the thrombotic complications of coronavirus disease 2019 (COVID-19). It is suggested that the hyperinflammatory response and endothelial injury, especially in patients with severe disease, lead to a hypercoagulable state. Sudden deaths occurring in some patients also point to fulminant arrhythmias and massive pulmonary embolism (PE). Several expert panels have published recommendations regarding the prophylaxis and treatment of such complications. Nonetheless, there are limited high-quality studies for evidence-based decision-making, and most of these recommendations have arisen from descriptive studies, and optimal anticoagulant agents and dosages are yet to be designated. The coagulopathy persists after the acute phase of the illness, and some panels recommend the continuation of deep vein thrombosis prophylaxis for several days after regaining the normal daily activities by the patient. Here, we review the incidence and possible mechanisms of thrombotic complications, and present a summary of the considerations for the prophylaxis and treatment of such complications in the adult population. |
|---|---|
| MeSH term(s) | Anticoagulants/administration & dosage ; COVID-19/complications ; Humans ; Incidence ; Platelet Aggregation Inhibitors ; Risk Factors ; Thrombophilia/drug therapy ; Thrombophilia/prevention & control ; Venous Thromboembolism |
| Chemical Substances | Anticoagulants ; Platelet Aggregation Inhibitors |
| Language | English |
| Publishing date | 2019-07-22 |
| Publishing country | Iran |
| Document type | Journal Article ; Review |
| ZDB-ID | 603872-4 |
| ISSN | 1735-3688 ; 0253-0716 |
| ISSN (online) | 1735-3688 |
| ISSN | 0253-0716 |
| DOI | 10.30476/ijms.2020.87233.1730 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.B 1634: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.